I am excited to see our latest collaborative work in Aging Cell doi.org/10.1111/acel... We explored muscle–brain cross-talk and discovered that the muscle-derived cathepsin B (a myokine) plays a key role in improving behavioral and neurogenic deficits in a mouse model of Alzheimer’s disease.
Muscle Cathepsin B Treatment Improves Behavioral and Neurogenic Deficits in a Mouse Model of Alzheimer's Disease
Targeting muscle with Cathepsin B (Ctsb) to treat the AD mouse brain. In this study, an AAV-vector-mediated approach, utilized to express Ctsb in muscle, prevented mnemonic and neurogenic deficits an...
doi.org